A Phase II Study to Assess Acute Toxicity and Quality of Life of Patients With Carcinoma of the Anal Canal Receiving Chemotherapy and Radiation Using Helical Tomotherapy
Phase 2
- Conditions
- Anal Canal Cancer
- Interventions
- Radiation: Tomotherapy
- First Posted Date
- 2008-09-17
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 58
- Registration Number
- NCT00754078
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients
Completed
- Conditions
- Testicular CancerNon-seminomatousSeminoma
- First Posted Date
- 2008-06-25
- Last Posted Date
- 2014-10-01
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 30
- Registration Number
- NCT00705094
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed Glioblastoma
Phase 1
Withdrawn
- Conditions
- Glioblastoma
- First Posted Date
- 2008-06-24
- Last Posted Date
- 2016-02-22
- Lead Sponsor
- AHS Cancer Control Alberta
- Registration Number
- NCT00703859
Individual Boosting in Non-Small Cell Lung Cancer Using Hypofractionation, Intensity-modulated Radiation Therapy and Respiratory Gating
Phase 1
- Conditions
- Carcinoma, Non-Small-Cell Lung
- First Posted Date
- 2008-06-05
- Last Posted Date
- 2016-04-06
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 12
- Registration Number
- NCT00690963
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Biological Investigations in Active Surveillance (BIAS) IGAR 2008 I 19 in Prostate Cancer Using High Field MRI (3 Tesla), PET, and Biomarkers
Phase 1
Completed
- Conditions
- Prostate Cancer
- First Posted Date
- 2008-05-13
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 26
- Registration Number
- NCT00676286
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Phase II Trial of Consolidative Thoracic Radiotherapy for Extensive Stage Small Cell Lung Cancer
Phase 2
Completed
- Conditions
- Extensive Stage Small Cel Lung Cancer
- First Posted Date
- 2008-03-26
- Last Posted Date
- 2016-02-26
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 30
- Registration Number
- NCT00643396
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Quantifying Lung Tumor Movement Under Deep Inspiration Breath Holds
Completed
- Conditions
- Lung Cancer
- Interventions
- Other: CT scan of the chest under deep inspiration breath hold
- First Posted Date
- 2008-03-26
- Last Posted Date
- 2016-02-17
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 8
- Registration Number
- NCT00643370
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
SU011248 for Platinum-Refractory Urothelial Cancer Evaluation Trial
Phase 2
Completed
- Conditions
- Urothelial CancerBladder CancerAdult
- Interventions
- Drug: Placebo
- First Posted Date
- 2007-12-21
- Last Posted Date
- 2018-08-22
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 64
- Registration Number
- NCT00578526
- Locations
- π¨π¦
Juravinski Cancer Centre, Hamilton, Ontario, Canada
π¨π¦Tom Baker Cancer Centre, Calgary, Alberta, Canada
π¨π¦Cross Cancer Institute, Edmonton, Alberta, Canada
A Phase I, Open-Labeled, Single-Arm, Dose Escalation, Clinical and Pharmacology Study of Dichloroacetate (DCA) in Patients With Recurrent and/or Metastatic Solid Tumours
Phase 1
Completed
- Conditions
- Neoplasms
- First Posted Date
- 2007-12-03
- Last Posted Date
- 2016-03-11
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 23
- Registration Number
- NCT00566410
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Novel Surrogate Markers as Predictors of Radiation Toxicity in Breast Cancer Patients Undergoing Helical Tomotherapy Compared to Standard Radiation Therapy
Terminated
- Conditions
- Breast and Skin MotionGenetic MarkersCardiac Toxicity
- First Posted Date
- 2007-11-26
- Last Posted Date
- 2016-02-24
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 16
- Registration Number
- NCT00563407
- Locations
- π¨π¦
Alberta Cancer Board, Edmonton, Alberta, Canada
Β© Copyright 2025. All Rights Reserved by MedPath